$Biodexa Pharmaceuticals (BDRX.US)$ CARDIFF, UK / ACCESSWIRE / November 21, 2024 / Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), an acquisition-focused clinical-stage biopharmaceutical company focused on developing treatments for unmet medical needs, has made significant progress in transforming itself from a drug delivery innovator to a therapeutics company with a focus on drugs to fight diabetes and cancer.
Biodexa's strategy is not based on discovering new medicines; rather it looks to redu...

$Real Messenger (RMSG.US)$ LOL THE CRASH

$Quantum Computing (QUBT.US)$ New highs!

$Conduit Pharmaceuticals (CDT.US)$ Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders
GlobeNewswire· 5 mins ago
Approval of composition of matter patent in key jurisdiction underscores the Company's commitment to maximize future out-licensing value

$Real Messenger (RMSG.US)$ shorts fighting to the death 🔥🔥🔥